Published: 2020-01-03

Articles

Stakeholders’ feedback on the proposed recommendations for updating the Patented Medicine Prices Review Board (PMPRB) budget impact analysis (BIA) guidelines

Naghmeh Foroutan, Jean-Eric Tarride, Feng Xie, Bismah Jameel, Fergal  Mills, Mitchell Levine
Abstract 419 | PDF Downloads 98 HTML Downloads 13 XML Downloads 1 | DOI https://doi.org/10.15586/jptcp.v27i1.651

Page e1-e24

PDF HTML XML

Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review

Ahmad Shakeri, Christopher Adanty
Abstract 239 | PDF Downloads 159 HTML Downloads 19 XML Downloads 0 | DOI https://doi.org/10.15586/jptcp.v27i1.655

Page e25-e31

PDF HTML XML

Validation of predictive equations for resting energy expenditure in treatment-seeking adults with overweight and obesity: Measured versus estimated

Leila Itani, Hana Tannir, Dima Kreidieh, Dana El Masri, Marwan El Ghoch
Abstract 161 | PDF Downloads 62 HTML Downloads 9 XML Downloads 0 | DOI https://doi.org/10.15586/jptcp.v27i1.653

Page e32-e47

PDF HTML XML

Alignment of Health Technology Assessments and Price Negotiations for New Drugs for Rare Disorders in Canada: Does It Lead to Improved Patient Access?

Nigel Rawson
Abstract 54 | PDF Downloads 13 XML Downloads 0 HTML Downloads 3

Page e48-e64

PDF XML HTML